Comparative Evaluation of Three Anxiety Control Protocols in Third Molar Extraction
Anxiety Disease
About this trial
This is an interventional treatment trial for Anxiety Disease focused on measuring Exodontia, Sedation, Nitrous Oxide, Benzodiazepines
Eligibility Criteria
Inclusion Criteria:
- Healthy patients (ASA1), without surgical contra indications, requiring avulsion of the included third and / or semi-molar third molars,
- Between the ages of 18 and 30,
- Patients who agreed to voluntarily participate in the research, after knowing the risks and benefits, and signing the Informed Consent Form (TCLE).
- Patients who presented moderate to high anxiety level in the questionnaire proposed by Corah in 1969.
Exclusion Criteria:
- Patients with any systemic or local change that contra indicated the procedure,
- Use of anti-inflammatories in the last 15 days,
- Pericoronitis,
- Patients who did not accept the Informed Consent Form (TCLE)
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
Diazepam
Midazolam
Nitrous Oxide + Oxygen Gas
Sedation of the anxious patient with diazepam 5 mg for measuring vital signs (blood pressure, heart rate, oxygen saturation) in the pre, trans and postoperative periods of third molar extraction.
Sedation of the anxious patient with midazolam 7.5 mg for measurement of vital signs (blood pressure, heart rate, oxygen saturation) in the pre, trans and postoperative periods of third molar extraction.
Inhaled sedation of the mixture of 40% of nitrous oxide and 60% of oxygen gas for measurement of vital signs (blood pressure, heart rate, oxygen saturation) in the pre, trans and postoperative periods of third molar extraction.